These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 4584162)

  • 1. Prevention of infected urinary stones by urease inhibition.
    Griffith DP; Musher DM
    Invest Urol; 1973 Nov; 11(3):228-33. PubMed ID: 4584162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of infected urinary stones by urease inhibitor. IV. Treatment of infection stones in rats by a new hydroxamic acid and cefalexin].
    Takeuchi H; Tomoyoshi T; Okada Y; Yoshida O; Kobashi K
    Hinyokika Kiyo; 1983 Mar; 29(3):297-302. PubMed ID: 6375315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.
    Takeuchi H; Kobashi K; Yoshida O
    Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
    Andersen JA
    Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus.
    Musher DM; Griffith DP; Yawn D; Rossen RD
    J Infect Dis; 1975 Feb; 131(2):177-81. PubMed ID: 234993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of bladder stones by L-forms.
    Braude AI; Siemienski J
    Trans Assoc Am Physicians; 1968; 81():323-31. PubMed ID: 5721409
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of acetohydroxamic acid on experimental proteus pyelonephritis.
    Maclaren DM
    Invest Urol; 1974 Sep; 12(2):146-9. PubMed ID: 4605277
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of infected urinary stones in rats by a new hydroxamic acid, "N-(pivaloyl)glycinohydroxamic acid.
    Takeuchi H; Okada Y; Kobashi K; Yoshida O
    Urol Res; 1982; 10(4):217-9. PubMed ID: 6758273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of infection stones. I. Dissolution of experimental infection stones in rats].
    Takeuchi H; Tomoyoshi T
    Hinyokika Kiyo; 1983 Mar; 29(3):293-6. PubMed ID: 6375314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of urinary catheter incrustations by acetohydroxamic acid.
    Burns JR; Gauthier JF
    J Urol; 1984 Sep; 132(3):455-6. PubMed ID: 6381758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
    Satoh M; Munakata K; Kitoh K; Seto N; Kanazawa T; Takeuchi H; Yoshida O
    J Pharmacobiodyn; 1981 Jul; 4(7):469-74. PubMed ID: 7028944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of acetohydroxamic acid on the induction of bacterial ureases.
    Rosenstein I; Hamilton-Miller JM; Brumfitt W
    Invest Urol; 1980 Sep; 18(2):112-4. PubMed ID: 6997229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones.
    Millner OE; Andersen JA; Appler ME; Benjamin CE; Edwards JG; Humphrey DT; Shearer EM
    J Urol; 1982 Feb; 127(2):346-50. PubMed ID: 7038144
    [No Abstract]   [Full Text] [Related]  

  • 16. The inflammatory reaction and urinary leucocytes in ascending urinary-tract infections. An experimental study on rabbits infected with Proteus vulgaris X 19 and Escherichia coli 06.
    Gnarpe H; Olding L
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(2):208-14. PubMed ID: 4922733
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of infection in urinary calculosis. Lithogenic effect in vitro of a Proteus mirabilis strain].
    Fontana G; Savoia D; Martinetto P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):352-61. PubMed ID: 4949683
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose propionhydroxamic acid therapy in infection-induced stones.
    Colussi G; Surian M; De Ferrari ME; Rombolà G; Rolando P; Minetti L
    Contrib Nephrol; 1987; 58():230-2. PubMed ID: 3691134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental magnesium ammonium phosphate lithiasis induced by Ureaplasma in the rat].
    Texier J; Clerc MT; Bébéar C; Aparicio M; Clerc M; Potaux L
    Nephrologie; 1984; 5(5):222-4. PubMed ID: 6531060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis.
    Satoh M; Munakata K; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1994 Aug; 40(8):689-94. PubMed ID: 7942366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.